Why digital therapeutics (DTx) are effective and safe, but not being prescribed episode artwork

EPISODE · Dec 19, 2023 · 20 MIN

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

from pharmaphorum Podcast · host pharmaphorum

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alliance (DTA), for a discussion on why it is that digital therapeutics (DTx) are effective and safe, but not being prescribed.

Episode metadata supplied by the publisher feed · Published Dec 19, 2023

Embed this episode

NOW PLAYING

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

0:00 20:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 20 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on December 19, 2023.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!